Market Cap (In INR)
190.72 Billion
Revenue (In INR)
20.09 Billion
Net Income (In INR)
3.91 Billion
Avg. Volume
284.14 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 809.15-1593.9
- PE
- -
- EPS
- -
- Beta Value
- 0.326
- ISIN
- INE406M01024
- CUSIP
- Y2R9KJ115
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Amit Indubhushan Bakshi
- Employee Count
- -
- Website
- https://www.eris.co.in
- Ipo Date
- 2017-06-30
- Details
- Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, antidiabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.
More Stocks
-
IFP
-
CITY
-
RSP
-
OIGLFChariot Limited
OIGLF
-
600562Glarun Technology Co.,Ltd
600562
-
ABSO
-
603808
-
EGYFEnergy Finders, Inc.
EGYF